Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Malstryx (99.02) Submitted: 9/12/2006 2:44:32 AM : Start Price: $10.15 NBIX Score: -43.82

Good pipeline in the works, approval is a ways off, getting in early for the ride back up.

JohnyRay (78.08) Submitted: 9/10/2006 10:41:02 PM : Start Price: $9.98 NBIX Score: -43.31

Huge amount of cash and promising pipeline. Recent bad news caused a huge downward overreaction in the share price.

trebor55 (27.97) Submitted: 8/25/2006 12:43:54 AM : Start Price: $11.05 NBIX Score: -49.86

Making necessary moves to survive until new drug hits the pipeline

Tarantula (27.45) Submitted: 7/20/2006 4:20:53 PM : Start Price: $9.70 NBIX Score: -44.35

The chips look down for NBIX - FDA delays, Pfizer pullout - but the stock is dirt cheap now, and the market is expecting the flagship product indipilon to evaporate completely. I think the clinical data is there to support a launch in the next 12-18 months, and I think that as this becomes more obvious to the wider market, the stock will recover quickly.

stratton6 (98.84) Submitted: 6/24/2006 6:47:16 PM : Start Price: $9.74 NBIX Score: -46.35

Looks like it might be a correction. The FDAs letter, albeit strangely worded, was not a rejection.

BreakerBeth (95.00) Submitted: 6/21/2006 8:41:12 PM : Start Price: $19.46 NBIX Score: -80.18

Grumble, I picked this one as a short term underperform when the FDA ruined Neurocrine's day not too long ago . . . and it was going up and up, and sentiment around here was strongly in favor of outperform . . . so I lost my nerve, canceled the underperform, changed it to outperform and like magic: NBIX tanked. So now my score's been crushed by this one twice.

Note to self: Lesson learned. Don't follow the crowd.